COMP <GO>
CPHI vs RMTI // GROSS PROFIT MARGIN
China Pharma Holdings Inc. (NYSE) VS. Rockwell Medical Inc. (NASDAQ) • 15-METRIC TALLY: CPHI 2
— RMTI 6
▲ GROSS PROFIT MARGIN LEADER: RMTI
LAST: $0.65 (+4.84%) • MKT CAP: $28.0M
gross-margins
-3.20%
LAST: $7.31 (0.00%) • MKT CAP: $29.5M
gross-margins
16.90%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CPHI VS. RMTI)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CPHI | RMTI | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | -3.20% | 16.90% | -20.10 | RMTI | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -11.40% | -10.60% | -0.80 | RMTI | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 0.32% | -2.24% | +2.56 | CPHI | /fcf-yield <GO> |
| Operating Margin | -60.00% | -6.80% | -53.20 | RMTI | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -7.70% | -52.30 | RMTI | /net-margins <GO> |
| Revenue Growth (YoY) | -8.50% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 3/9 | +1.00 | CPHI | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 40.2 | 41.0 | -0.82 | RMTI | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $28.0M | $29.5M | -$1.5M | RMTI | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CPHI REV | RMTI REV | CPHI GROSS % | RMTI GROSS % | CPHI FCF | RMTI FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $4.1M | $69.3M | -3.2% | 16.9% | $88.9K | -$659.0K |
| FY 2024 | $4.5M | $101.5M | -43.8% | 17.2% | -$444.5K | $4.2M |
| FY 2023 | $7.0M | $0 | — | — | -$699.7K | -$9.4M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CPHI // BETA —
RMTI // BETA —